Helen is a Birmingham University Medical graduate who started working in the field of Public Health in 2001. She has worked for many different organisations during this time including Health Authorities, Primary Care Trusts, and Strategic Health Authority on a wide range of projects and programs. She joined Public Health England when it was formed in 2013. Her portfolio is currently very diverse and includes being the PHE Children and Young People Executive Team sponsor and the Vice chair of the West Midlands Clinical Senate.
Dr Matt Kearney is a general practitioner and National Clinical Director for Cardiovascular Disease Prevention in England. He has been working for both NHS England and Public Health England since 2013, building a national programme to improve prevention of cardiovascular disease. In particular, he has focused on mobilising the wider primary care system to support earlier detection and improved management of conditions such as hypertension, atrial fibrillation, and raised cholesterol.
From 2009 to 2014, Matt worked as an advisor to the Department of Health helping develop a national respiratory strategy, and from 2005 to 2013, was a member of Public Health Interventions Advisory Committee at the National Institute for Health and Care Excellence. He graduated in Medicine from the University of Birmingham and obtained a Master's Degree in Public Health from the University of Liverpool in 2003. He is a Fellow of the Royal College of Physicians and a Fellow of the Royal College of General Practitioners.
Professor Lip, MD, is Professor of Cardiovascular Medicine at the University of Birmingham and is based in a busy city centre teaching hospital. He is also Adjunct Professor of Cardiovascular Sciences, Aalborg University, Denmark.
Half of his time is spent as a clinical cardiologist, and he practises the full range of cardiovascular medicine, including outpatient clinics (leading large atrial fibrillation and hypertension specialist services), interventional cardiology and coronary care unit.
Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines.
He was selected to the Thomson Reuters Science Watch list of ‘World’s Most Influential Scientific Minds 2014’, a ranking of today’s top 17 scholars who have published the greatest number of hot papers, ranked in the top 0.1% by citations, [issued June 2014; see website: http://bit.ly/1sx4uyM]. In 2014, Professor Lip was ranked by Expertscape as one of the world's leading experts in the understanding and treatment of AF [http://bit.ly/2apB1Dt].
Professor Lip is a board member of the European Heart Rhythm Association (EHRA) and is Chairman of its scientific documents committee (2013-).
Professor Lip was on the writing committee for various international guidelines, including the American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from the European Society of Cardiology (ESC) or EHRA. Specifically, he was also on the writing committees of the 2010 ESC Guidelines on Atrial Fibrillation, the 2012 ESC Focused Update Guidelines on Atrial Fibrillation, the 2012 ESC Guidelines on Heart Failure, and the 2014 NICE guidelines on AF. He was Deputy Editor (“content expert”) for the 9th ACCP guidelines on antithrombotic therapy for AF (2012).
Professor Lip has acted as senior/section editor for major international textbooks and at senior editorial level for major international journals, including Thrombosis & Haemostasis (Editor-in-Chief, Clinical Studies); Europace (Associate Editor); and Circulation (Guest Editor).
Shakti Dookeran is a Population Health Service Manager at Public Health England (PHE) and has been leading the national Atrial Fibrillation (AF)-related stroke prevention programme for the past three years. In this role Shakti uses her leadership skills to energise and influence partner agencies to work collaboratively and share resources more effectively across the system, both at national and local levels. The programme aims to improve outcomes for people with AF by helping to tackle system-wide challenges, such as improving access to data, disseminating good practice and strengthening clinical leadership.
Working with the Academic Health Science Network, voluntary sector, NHS Right Care, NHS England and other agencies, Shakti successfully gained consensus on a national ambition to prevent 5000 AF-related strokes over the next 5 years and led the delivery of two successful AF-related stroke prevention events in 2016. These events brought together providers and commissioners and provided a platform for learning and wider adoption of resources and support. The success of these events beckoned a call for further regional events which will be delivered over 2017 and 2018.
Before joining PHE, Shakti worked in the Public Health team in the diverse borough of Tower Hamlets for five years where she moved through several roles working on areas such as sexual health, mental health, healthy lifestyles and drugs and alcohol. Shakti led a range of primary and secondary prevention projects which involved engaging and influencing stakeholders to agree priority areas for joint action and delivery. Shakti has a special interest in innovative approaches to prevention and led a highly publicised project ‘Faith in Health’ which raised population awareness of health promotion messages and services through roadshows, community events and religious leader health champions.
Shakti holds a Master’s Degree in Public Health from The London School of Hygiene and Tropical Medicine and recently completed a M.Sc. in Health Policy at Imperial College London with a major in Shared Leadership.
Sotiris is Consultant Pharmacist at Barts Heart Centre, part of Barts Health NHS Trust. Combined with his role as Lead Cardiovascular Pharmacist for UCL Partners supports medicines optimisation across the health economy to optimise patient outcomes and address unmet local needs.
He is an independent prescriber and is currently chair of the cardiac committee for United Kingdom Clinical Pharmacy Association (UKCPA). He is chair of the international Pharmacist Anticoagulation Taskforce (iPACT). An international group of over 20 countries aimed to improve pharmaceutical care around anticoagulants, by providing background materials and stimulating pharmacists to provide appropriate care to their patients. Sotiris is also a member of the Atrial Fibrillation Association medical advisory panel.
He has published extensively in the medical press and has a particular interest in in improving anticoagulation for stroke prevention in atrial fibrillation. Sotiris has been successful in obtaining a Lord Darzi funded fellow to ‘co-design and test a new referral pathway for people with atrial fibrillation with community pharmacists’ with the aim to support individuals understanding of their condition and their therapy with the ultimate aim of optimising adherence. Sotiris is also a member of the ‘AF-SCREEN International collaboration’ that produced a white paper titled ‘Screening for Atrial Fibrillation’. The AF-SCREEN international collaboration was formed in September 2015 to promote discussion and research about AF screening as a strategy to reduce stroke and death and to provide advocacy for implementation of country-specific AF screening programs.
He is actively involved in the training and development of clinical pharmacists including developing a curriculum and assessment tool for advanced and consultant level specialist cardiac pharmacists working with the UKCPA and Royal Pharmaceutical Society.
Sotiris has served on many NICE development groups including Unstable Angina/NSTEMI guideline, stable angina and STEMI guidelines and is a current NICE TA member of the highly specialist technology appraisal group. He is also a member of the London Strategic Clinical Network Cardiovascular Leadership Group and NHS England Medicines Optimisation Intelligence Group meeting. Sotiris is also an honorary senior research associate at UCL School of Pharmacy.
Specialist Training was in the West Midlands during which time he developed a Special Interest in Stroke Medicine. He did Stroke Fellowship year at St. Mary’s Hospital London for training in all aspects of Specialist Stroke Care.
Appointed as Consultant Stroke Physician at University Hospital of North Midlands in Jan 2008. Following his work regionally on Stroke thrombolysis training and contribution to the Stroke Services to the local health economy he was appointed as the Clinical Lead for Stroke for the Heart and Stroke Network for Shropshire and Staffordshire in May 2010. Since then he has been working on all areas of stroke care to improve the quality of Stroke services delivered locally and regionally.
He championed the setting up of Nurse led AF stroke prevention service in July 2014 which has now screened 3500 patients seen 1200 patients anti-coagulated around 800 patients and treatments changed for 1100 patients and thereby preventing 34 catastrophic strokes and saving the health economy of around 1 million pounds.
He is currently the Clinical Director for Stroke for the West Midlands Strategic Clinical Network NHS England and National Clinical Lead for the Hyper-acute Stroke Research Centre’s.
Hilton Birmingham Metropole
From Birmingham International Airport, bear right onto Concorde Road, turn right onto Vanguard Road and then bear left onto Airport Way. At the roundabout take the 3rd exit then merge onto Coventry Road A45 (sign posted M42, M6, M1, M40, M5, Coventry). Branch left (sign posted M42, M6, M1, M40, M5, NEC), then at the roundabout take the first exit onto Pendigo Way (sign posted NEC). At the roundabout take the first exit into the car park of the Hilton Birmingham Metropole.
Registration is free for healthcare professionals within the UK who have a special interest in AF. Please note that spaces are limited and available on a first-come first-serve basis.